MetLife Investment Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Sell
18,559
-1,038
-5% -$173K 0.01% 945
2026
Q1
$4.11M Sell
19,597
-645
-3% -$162K 0.02% 709
2025
Q4
$5.75M Sell
20,242
-541
-3% -$169K 0.03% 564
2025
Q3
$6.42M Sell
20,783
-335
-2% -$105K 0.03% 521
2025
Q2
$6.63M Sell
21,118
-132
-0.6% -$38.1K 0.04% 452
2025
Q1
$5.58M Sell
21,250
-388
-2% -$105K 0.03% 553
2024
Q4
$5.65M Buy
21,638
+233
+1% +$58.7K 0.03% 488
2024
Q3
$4.98M Sell
21,405
-509
-2% -$105K 0.03% 529
2024
Q2
$4.42M Buy
21,914
+2,713
+14% +$489K 0.03% 559
2024
Q1
$3.29M Sell
19,201
-593
-3% -$111K 0.02% 732
2023
Q4
$4.29M Sell
19,794
-350
-2% -$60K 0.03% 560
2023
Q3
$3.21M Sell
20,144
-423
-2% -$94.7K 0.03% 672
2023
Q2
$5.93M Sell
20,567
-89
-0.4% -$27K 0.04% 361
2023
Q1
$6.59M Buy
20,656
+16,494
+396% +$4.89M 0.05% 323
2022
Q4
$1.23M Sell
4,162
-110
-3% -$30.3K 0.01% 1111
2022
Q3
$980K Buy
4,272
+3
+0.1% +$751 0.01% 1201
2022
Q2
$930K Sell
4,269
-10
-0.2% -$2.27K 0.01% 1244
2022
Q1
$1.14M Buy
+4,279
New +$1.05M 0.01% 1251
2019
Q2
Sell
-80
Closed -$7.61K 2560
2019
Q1
$7.61K Hold
80
﹤0.01% 2433
2018
Q4
$6.35K Hold
80
﹤0.01% 2438
2018
Q3
$8.48K Buy
+80
New +$7.49K ﹤0.01% 2462
2018
Q2
Sell
-26,143
Closed -$2.27M 2211
2018
Q1
$2.27M Hold
26,143
0.03% 732
2017
Q4
$1.8M Buy
+26,143
New +$1.72M 0.02% 819

Other funds holding PODD

MetLife Investment Management's PODD Position: Q2 2026 in Review

MetLife Investment Management reduced its Insulet (PODD) stake by 5.3% in Q2 2026, selling an estimated $173K and leaving 18,559 shares worth $2.83M. The position accounts for 0.01% of the portfolio, ranked #945.

MetLife Investment Management first reported a position in PODD in Q4 2017 and has held it in 23 quarters since. The position peaked at $6.63M in Q2 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • MetLife Investment Management held 18,559 shares of Insulet worth $2.83M as of Q2 2026.
  • MetLife Investment Management sold 1,038 Insulet shares in Q2 2026, an estimated $173K.
  • Insulet made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #945 holding.
  • MetLife Investment Management first reported a position in Insulet in Q4 2017 and has held it in 23 quarters since.
  • MetLife Investment Management's Insulet position peaked at $6.63M in Q2 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.